Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Marking a significant milestone in the global effort to expand access to advanc...
As India moves into 2026, industry experts state that the next phase of growth ...
Hongene Biotech announced the receipt of a grant from the Gates Foundation to d...
Jubilant Biosys, a wholly owned subsidiary of Jubilant Pharmova, and a global ...
The American Association of Physicians of Indian Origin (AAPI), in collaboratio...
Alembic Pharmaceuticals announced that it has received tentative approval from...
Under the agreement, MediLink will receive upfront and near-term milestone payme...
The facility forms a key component of the company’s $23bn US investment programm...
How does IGMPI’s training ecosystem directly address the root causes of patient...
Syngene International, an integrated research, development and manufacturing se...
Agamree is a new drug that operates by attaching to the same receptor as glucoco...
Through this partnership, Takeda aims to enhance patient care while exploring ne...
Anil Matai, Director General, OPPI: “As India approaches the upcoming Union Bud...
What motivated you to write Quality Trailblazer, and how does it address the mo...
The recently held Odisha Pharma Summit 2025, the state’s first dedicated summit...
Recently, the Indian Ministry of Health and Family Welfare issued a government ...